Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
Notwendige Cookies
Diese Cookies sind für das Funktionieren des Logins und die Speicherung der Cookie-Einstellungen erforderlich und können deshalb nicht deaktiviert werden.
Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
Synlait Milk will sell several of its New Zealand assets to Abbott Laboratories for NZ$307 million ($177 million), enabling it to reset its balance sheet after a period of losses and underperformance....
The ASX will welcome the $2.1 billion Ryman Healthcare to the bourse next week.
The post New Zealand's largest retirement living provider to list on the ASX next week appeared first on The Motley Fool Australia....
The ASX 200 is surging on Friday after new records were set on Wall Street last night.
The post Life360 and Neuren Pharmaceuticals among 9 ASX 200 shares hitting multi-year highs appeared first on The Motley Fool Australia....
These shares are falling more than most today. But why?
The post Why 4DMedical, BlueScope, EOS, and Spark NZ shares are falling today appeared first on The Motley Fool Australia....
These shares are ending the week with a bang. But why?
The post Why 4DMedical, Lotus Resources, Vulcan Energy, and Xero shares are storming higher today appeared first on The Motley Fool Australia....
These shares are having a strong session on Thursday. But why?
The post Why EOS, Eroad, Neuren, and Westgold shares are roaring higher today appeared first on The Motley Fool Australia....
We review the share price growth and dividend income delivered to investors in FY25.
The post Which delivered superior returns in FY25: CSL, A2 Milk, or Telstra shares? appeared first on The Motley Fool Australia....
These shares are having a strong session on Thursday. But why?
The post Why DroneShield, Neuren, Paradigm, and Pilbara Minerals shares are roaring higher today appeared first on The Motley Fool Australia....
The broker described Neuren as a standout in the ASX biotech sector.
The post Macquarie initiates coverage of Neuren Pharmaceuticals shares; forecasts 45% upside appeared first on The Motley Fool Australia....
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares have been on form over the past 12 months. During this …
The post Why does Macquarie think Fisher & Paykel shares are a buy? appeared first on The Motley Fool Australia....
These shares are having a tough time on hump day. But why?
The post Why ALS, Fisher & Paykel Healthcare, IPD, and Predictive Discovery shares are falling today appeared first on The Motley Fool Australia....
These shares are having a better day than most today. But why?
The post Why Boss Energy, Neuren, Strickland, and Vulcan shares are pushing higher today appeared first on The Motley Fool Australia....
Will the ASX 200 healthcare stock continue to outperform?
The post Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result? appeared first on The Motley Fool Australia....
Oceania Healthcare and Summerset could quietly emerge as high-upside plays for patient ASX investors.
The post Why Macquarie thinks the NZ retirement village sector could be an emerging opportunity for ASX investors appeared first on The Motley Fool Australia....